Triptans: Do they differ?
- 1 April 2002
- journal article
- research article
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 6 (2) , 133-139
- https://doi.org/10.1007/s11916-002-0009-6
Abstract
Headache care specialists agree that the introduction of sumatriptan constitutes a major advance in headache therapy, but they differ about whether other triptans offer clinically significant advantages over sumatriptan. This article examines this issue by considering the similarities and differences among triptans.Keywords
This publication has 44 references indexed in Scilit:
- Triptans in MigraineDrugs, 2000
- Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum StudyHeadache: The Journal of Head and Face Pain, 2000
- Tolerability of sumatriptan: clinical trials and post-marketing experienceCephalalgia, 2000
- Drug Comparisons: Why are They so Difficult?Cephalalgia, 2000
- ZolmitriptanDrugs, 1999
- Oral Rizatriptan Versus Oral Sumatriptan: A Direct Comparative Study in the Acute Treatment of MigraineHeadache: The Journal of Head and Face Pain, 1998
- Crossover Comparison of Rizatriptan 5 mg and 10 mg Versus Sumatriptan 25 mg and 50 mg in MigraineHeadache: The Journal of Head and Face Pain, 1998
- Acute migraine therapyCurrent Opinion in Neurology, 1997
- Efficacy of subcutaneous sumatriptan in the acute treatment of early‐morning migraine: a placebo‐controlled trialJournal of Internal Medicine, 1993
- 5-HT1-like receptor agonists and the pathophysiology of migraineTrends in Pharmacological Sciences, 1989